Normally, chasing rainbows is an inherently futile act. Masimo’s pursuit, however, is the rare one proven fruitful, with a new CE mark for its Rainbow SuperSensor. The single-use, adhesive SuperSensor ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ ...
Masimo has earned a CE mark for a reusable finger sensor that noninvasively measures a range of physiological parameters at the same time. This reduces the need to use multiple sensors in patient ...
Zacks.com on MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...
Masimo Corporation, a global medical technology company announced FDA 510(k) clearance of Radius PPG, a tetherless sensor solution powered by Masimo SET that represents a significant breakthrough in ...
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...
Masimo Corporation MASI recently announced the receipt of the FDA’s clearance for Stork for prescription use with healthy and sick infants aged 0-18 months of age. Stork, Masimo’s innovative baby ...
As Apple starts selling Apple Watch Series 9 and Ultra 2 models without the blood oxygen sensor enabled, Masimo CEO Joe Kiani confirmed to Bloomberg that there has been no chat with Apple about a ...
(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback